Wide Ranks

ANEB

Anebulo Pharmaceuticals, Inc.

1.43

Top Statistics
Market Cap 37 M Forward PE -2.20 Revenue Growth 0.00 %
Current Ratio 13.46 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 3 M Total Cash Per Share 0.1190 Total Debt
Total Debt To Equity Current Ratio 13.46 Book Value Per Share 0.1470
All Measures
Short Ratio 194.00 % Message Board Id finmb_673614867 Shares Short Prior Month 14527
Return On Equity -1.14 City Lakeway Uuid fc68cd91-6097-3786-8f7e-3d915060bcb8
Previous Close 1.50 First Trade Date Epoch Utc 1 B Book Value 0.1470
Beta -1.01 Volume 10023 Price To Book 9.73
Fifty Two Week Low 1.25 Total Cash Per Share 0.1190 Shares Short Previous Month Date 1 B
Target Median Price 8.00 Max Age 86400 Recommendation Mean 1.00
Sand P52 Week Change 0.3133 Target Mean Price 8.00 Net Income To Common -8201703
Short Percent Of Float 0.0028 Implied Shares Outstanding 25 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 5880 Average Volume10days 5880
Total Cash 3 M Next Fiscal Year End 1 B Held Percent Insiders 0.6422
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 1.50 Target Low Price 8.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.82 Open 1.59 Free Cashflow -5176637
State TX Dividend Yield 0.00 % Return On Assets -0.6597
Time Zone Short Name EST Trailing Eps -0.3000 Day Low 1.43
Address1 1017 Ranch Road 620 South Shares Outstanding 25 M Price Hint 4
Target High Price 8.00 Website https://www.anebulo.com 52 Week Change -0.3728
Average Volume 8982 Forward Eps -0.6500 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 1187.40 % Is_sp_500 False
Regular Market Day High 1.59 Profit Margins 0.00 % Fifty Two Week High 3.30
Day High 1.59 Shares Short 10758 Regular Market Open 1.59
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0004 Operating Cashflow -8090849 Currency USD
Time Zone Full Name America/New_York Market Cap 37 M Is_nasdaq_100 False
Zip 78734 Quote Type EQUITY Industry Biotechnology
Long Name Anebulo Pharmaceuticals, Inc. Regular Market Day Low 1.43 Held Percent Institutions 0.2832
Current Price 1.43 Address2 Suite 107 Financial Currency USD
Current Ratio 13.46 Industry Disp Biotechnology Number Of Analyst Opinions 1
Country United States Float Shares 3 M Two Hundred Day Average 2.27
Enterprise Value 36 M Forward PE -2.20 Regular Market Volume 10023
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.

Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity.

The company was incorporated in 2020 and is based in Lakeway, Texas.